NCT05635331 Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece Status COMPLETED Phase N/A
NCT05630677 A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT05629585 A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05629234 Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Osimertinib (TAGRISSO) (ROSY-T) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05624450 Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen Status RECRUITING Phase PHASE3
NCT05617963 Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05607719 Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05603845 Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients Status COMPLETED Phase N/A
NCT05592483 An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer Status TERMINATED Phase N/A
NCT05590702 French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05587998 A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users. Status COMPLETED Phase PHASE1
NCT05583227 Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05583149 Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05582538 Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel Status RECRUITING Phase PHASE2
NCT05573893 PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan Status RECRUITING Phase N/A
NCT05573724 Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT05573464 A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT05572476 Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT05570305 Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria Status COMPLETED Phase PHASE2